This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
Yesterday’s UK 100 Leaders | Price (p) | % Chg |
Rolls-Royce Holdings PLC | 93.5 | 3.2% |
Phoenix Group Holdings PLC | 611.4 | 2.6% |
Barclays PLC | 158.8 | 1.6% |
Bae Systems PLC | 826.0 | 1.2% |
Smith (Ds) PLC | 308.9 | 1.2% |
Yesterday’s UK 100 Laggards | Price (p) | % Chg |
Mondi PLC | 1468.0 | -4.7% |
Scottish Mortgage Investment Trust PLC | 755.8 | -3.1% |
Endeavour Mining PLC | 1697.0 | -3.0% |
Dechra Pharmaceuticals PLC | 2680.0 | -3.0% |
Halma PLC | 2160.0 | -2.6% |
Major World Indices | Price | % Chg | 1 YEAR |
UK 100 INDEX | 7,521 | -0.6% | 2.5% |
DOW JONES INDUS. AVG | 33,596 | -1.0% | -5.9% |
DAX INDEX | 14,343 | -0.7% | -6.8% |
NIKKEI 225 | 27,686 | -0.7% | -2.7% |
S&P/ASX 200 INDEX | 7,229 | -0.9% | -1.2% |
Commodities | Units | Price | % Chg |
WTI Crude Oil (Nymex) | USD/bbl. | 74.26 | 0.01% |
Brent Crude (ICE) | USD/bbl. | 79.44 | 0.11% |
Gold Spot | USD/t oz. | 1,774 | 0.2% |
Copper (Comex) | USd/lb. | 379 | -0.8% |
The UK 100 is called to open +12 points this morning at 7533. The UK 100 is expected to open higher today shrugging aside hefty losses in the US and UK housing price data showing the fastest fall for 14 years this morning, as China announced a nationwide loosening of its strict zero-Covid measures. China will now allow people with asymptomatic COVID-19 or mild symptoms to quarantine at home in another relaxation of its rules. In the US markets fell again as uncertainty around the pace and direction of Federal Reserve rate hikes and further talk of a looming recession dented sentiment. The S&P fell for a fourth day in a row, closing 58 points lower, or 1.44%, to 3,941, the Dow Jones slipped 351 points, or 1.03%, to 33,596 and the Nasdaq dipped 225 points, or 2%, to 11,015.
.
Games Workshop says their trading is in line with expectations since their last update in September.
GlaxoSmithKline have been spared thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer after the federal multi-district litigation court states there is no reliable evidence that ranitidine increases risk of any cancer.
Mitchells & Butlers flagged challenges arising from surging energy and labour costs after the British pub and restaurant group posted higher annual profit. Their operating profit grew to £124m in the FY ended Sept 24th (2021: £81m profit).
Moonpig H1 pretax profit halves to £9.1m from £18.7m YoY, as their selling and admin expenses widen to £63m from £47m YoY. They state expectations for FY23 adjusted EBITDA is unchanged as they state trading conditions are progressively more challenging through Oct and Nov.
Barclays Upgrades Haleon to Overweight from Equal Weight (5 Buys / 7 Holds / 0 Sells)
Jefferies Downgrades PageGroup to Underperform from Hold (5 Buys / 4 Holds / 0 Sells)
JP Morgan Downgrades Johnson Matthey to Underweight from Neutral (5 Buys / 11 Holds / 1 Sell)
Moonpig Group
Redde Northgate
Monks Investment Trust
Paragon Banking Group
Tritax Eurobox
DS Smith
Chinese Imports
Chinese Exports
Chinese Trade Balance
EU Gross Domestic Product
US Nonfarm Productivity
Japanese Gross Domestic Product
UK 100 companies going ex-dividend on 8th December 2022:
Intermediate Capital Group
JD Sports Fashion
UK 250 companies going ex-dividend on 8th December 2022:
Sirius Real Estate
Investec
Liontrust Asset Management
Energean
SDCL Energy Efficiency Income Trust
Assura
Shaftesbury
Temple Bar Investment Trust
Johnson Matthey
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.